Currencies / LUCD
LUCD: Lucid Diagnostics Inc
1.26
USD
0.06
(5.00%)
LUCD exchange rate has changed by 5.00% for today. During the day, the instrument was traded at a low of 1.21 and at a high of 1.31.
Follow Lucid Diagnostics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
LUCD News
- Lucid Diagnostics stock holds steady as BTIG reiterates Buy rating
- Cantor Fitzgerald reiterates Overweight rating on Lucid Diagnostics stock
- Lucid Diagnostics Inc. (LUCD) Q2 2025 Earnings Call Transcript
- Lucid Diagnostics Inc. (LUCD) Reports Q2 Loss, Tops Revenue Estimates
- Lucid Diagnostics earnings beat, revenue was in line with estimates
- LUCD Reports Results
- Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Misses Revenue Estimates
- Inogen (INGN) Reports Q2 Loss, Beats Revenue Estimates
- Mesa Labs (MLAB) Lags Q1 Earnings and Revenue Estimates
- Hologic (HOLX) Q3 Earnings and Revenues Beat Estimates
- Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics’ EsoGuard ® Esophageal DNA Test
- Ascendiant Capital raises Lucid Diagnostics stock price target to $7.75
- SAIC, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Algoma Steel Group (NASDAQ:ASTL), Arvinas (NASDAQ:ARVN)
- Lucid Diagnostics to join Russell 2000 and Russell 3000 indexes
- Cantor Fitzgerald maintains Lucid Diagnostics stock Overweight
- PAVmed Q1 2025 slides: net income soars amid strategic restructuring
- Cantor maintains Lucid Diagnostics stock with $2 target after Q1 results
- Lucid Diagnostics earnings beat by $0.03, revenue fell short of estimates
- Lucid Diagnostics: DNA Testing To Get Medicare Coverage, Driving Volumes, Says Bullish Analyst - Lucid Diagnostics (NASDAQ:LUCD)
- Lucid Diagnostics Inc. 2024 Q4 - Results - Earnings Call Presentation (NASDAQ:LUCD)
Daily Range
1.21
1.31
Year Range
0.73
1.81
- Previous Close
- 1.20
- Open
- 1.22
- Bid
- 1.26
- Ask
- 1.56
- Low
- 1.21
- High
- 1.31
- Volume
- 936
- Daily Change
- 5.00%
- Month Change
- 24.75%
- 6 Months Change
- -15.44%
- Year Change
- 57.50%
31 August, Sunday